Atea Pharmaceuticals
Price & Volume
Stats
See more52W Range | $2.45-$4.02 |
Market Cap | $267.9M |
Shares Short | 6M |
Financials
See moreRevenue (12 Mos) | $192.1M |
Revenue Growth (YoY) | 295.2% |
Gross Profit (12 Mos) | -$120M |
Diluted EPS | -$1.77 |
News
See moreYahoo Finance • 5 days ago
Atea Pharmaceuticals Completes Patient Enrollment in North American Phase 3 Trial Evaluating Regimen of Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus
Yahoo Finance • 9 days ago
Nano Dimension And 2 Other Penny Stocks With Promising Potential
Yahoo Finance • last month
Atea Pharmaceuticals to Present at the 8th Annual Evercore Healthcare Conference
Yahoo Finance • last month
3 Promising Penny Stocks With Market Caps As Low As $200M
About
CEO | Dr. Jean-Pierre Sommadossi Ph.D. |
CFO | Ms. Andrea J. Corcoran J.D. |
Address | 225 Franklin Street, Boston, MA, United States, 02110 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 56 |
